NCT07620678

Brief Summary

Lateral epicondylitis is a common musculoskeletal disorder associated with pain and impaired upper extremity function. The aim of this study was to compare the effectiveness of extracorporeal shock wave therapy (ESWT) and single-session 5% dextrose prolotherapy (DPT) in patients with lateral epicondylitis and to evaluate the relative superiority of these treatment approaches during short- and mid-to-long-term follow-up. Ninety-six patients were allocated into three groups: conventional treatment alone, conventional treatment plus ESWT, and conventional treatment plus DPT. Pain, functional status, grip strength, and common extensor tendon thickness were evaluated during follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 29, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

1.9 years

First QC Date

May 27, 2026

Last Update Submit

May 27, 2026

Conditions

Keywords

Lateral EpicondylitisTennis ElbowDextrose ProlotherapyESWTExtracorporeal Shock Wave

Outcome Measures

Primary Outcomes (4)

  • VAS Resisted Wrist Extension Pain

    Pain during resisted wrist extension assessed using the Visual Analog Scale (VAS).

    Baseline, 1 month, 3 months, and 6 months after treatment

  • VAS Gripping Pain

    Pain intensity during gripping assessed using the Visual Analog Scale (VAS).

    Baseline, 1 month, 3 months, and 6 months after treatment

  • VAS Resting Pain

    Resting pain assessed using the Visual Analog Scale (VAS).

    Baseline, 1 month, 3 months, and 6 months after treatment

  • VAS Night Pain

    Night pain assessed using the Visual Analog Scale (VAS).

    Baseline, 1 month, 3 months, and 6 months after treatment

Secondary Outcomes (4)

  • Quick-DASH Score

    Baseline, 1 month, 3 months, and 6 months after treatment

  • PRTEE Score

    Baseline, 1 month, 3 months, and 6 months after treatment

  • Grip Strength

    Baseline and 6 months

  • Common Extensor Tendon Thickness

    Baseline and 6 months

Study Arms (3)

Conventional Treatment + ESWT

ACTIVE COMPARATOR

Three treatment sessions administered at weekly intervals using 2000 pulses per session at an energy flux density of 0.15 mJ/mm².

Behavioral: Conventional Treatment groupDevice: Extracorporeal Shock Wave Therapy (ESWT)

Conventional Treatment + Dextrose Prolotherapy

ACTIVE COMPARATOR

Single-session ultrasound-guided injection of 1 mL 5% dextrose.

Behavioral: Conventional Treatment groupProcedure: Dextrose prolotherapy (DPT)

Conventional Treatment

ACTIVE COMPARATOR

Splinting and home exercise program.

Behavioral: Conventional Treatment group

Interventions

Splinting and home exercise program

Conventional TreatmentConventional Treatment + Dextrose ProlotherapyConventional Treatment + ESWT

3 sessions, weekly, 4Hz, 2000 pulses/session, 0.15 mJ/mm².

Conventional Treatment + ESWT

Single-session ultrasound-guided 1 mL 5% dextrose injection.

Conventional Treatment + Dextrose Prolotherapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-75 years
  • Clinical and ultrasonographic diagnosis of lateral epicondylitis
  • Symptoms persisting for at least 3 months
  • Visual Analog Scale (VAS) score ≥4
  • Resistance to previous medical treatment
  • Ability to comply with study procedures and complete questionnaires

You may not qualify if:

  • Injection treatment for lateral epicondylitis within the previous 3 months
  • History of trauma within the previous 3 months
  • Cervical disc herniation
  • Median or ulnar tunnel neuropathy
  • Medial epicondylitis
  • Anticoagulant therapy use
  • Pregnancy or breastfeeding
  • Psychiatric disorders or cognitive impairment interfering with questionnaire -completion
  • Allergy to the treatment solution
  • History of upper extremity surgery or fracture
  • Rheumatoid arthritis
  • Connective tissue diseases such as dermatomyositis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SBU Ankara Physical Medicine and Rehabilitation Training and Research Hospital Ankara, Turkey

Ankara, Cankaya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Tennis Elbow

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were allocated into three parallel groups: conventional treatment alone, conventional treatment plus extracorporeal shock wave therapy (ESWT), and conventional treatment plus single-session 5% dextrose prolotherapy.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

May 27, 2026

First Posted

June 2, 2026

Study Start

October 1, 2023

Primary Completion

August 29, 2025

Study Completion

August 29, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be publicly shared due to institutional and ethical restrictions regarding patient confidentiality.

Locations